Angiodynamics (ANGO) Depreciation and Depletion (2014 - 2015)
Angiodynamics posted quarterly Depreciation and Depletion of $9.4 million for Q2 2015, up 2250.0% on a QoQ basis from $400000.0 in Q3 2014.
Angiodynamics (ANGO) has 2 years of Depreciation and Depletion data on file, last reported at $9.4 million in Q2 2015.
- For the quarter ending Q2 2015, Depreciation and Depletion changed N/A year-over-year to $9.4 million; the trailing twelve-month figure through May 2015 stood at $9.8 million (changed N/A YoY), and the FY2025 full-year result was $13.5 million, down 8.16% from the prior year.
- Depreciation and Depletion for Q2 2015 stood at $9.4 million, up from $400000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $9.4 million in Q2 2015 and bottomed at $400000.0 in Q3 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | - |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | - |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 44.60 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 38.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 47.60 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 15.60 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 91.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 64.31 Mn |
| 10 | Angiodynamics | 497.07 Mn | 459.26 Mn | 41.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2015 | 9.40 Mn |
| May 31, 2015 | 9.40 Mn |
| Aug 31, 2014 | 400,000.00 |
| Aug 31, 2014 | 400,000.00 |